The most comprehensive and go-to place for all short selling reseach reports online.
Currently a total of 275 research reports from 14 investment research firms has been aggregated, with new reports being added and updated constantly
ALL
Fuzzy Panda Research(8)
Hindenburg Research(52)
MuddyWaters(44)
Blue Orca Capital(35)
Gotham City Research LLC(11)
Anonymous Analytics(5)
J Capital Research(26)
Grizzly Research LLC(22)
Jehoshaphat Research(10)
Culper Research(20)
Ningi Research(4)
Night Market Research(14)
Ontake Research(2)
Bonitas Research(22)
ALL
0067(1)
0607(1)
0773(1)
1044(1)
1228(1)
1259(1)
1360(6)
1619(1)
1636(1)
1717(1)
1910(1)
1999(1)
2018(1)
2020(1)
2200(1)
3823(1)
3836(1)
3998(1)
404(1)
4587(1)
496(1)
555(1)
6186(1)
6594(1)
669.HK(1)
6863(1)
8207(2)
867(1)
ACB(1)
ACMR(1)
AGFY(1)
AHCO(1)
AHG(1)
AMEH(1)
AMT(1)
AMTX(1)
AOS(1)
APHA(1)
AR4(1)
AR4.DE(1)
ARMC(1)
ARRY(1)
ATEC(1)
ATER(1)
ATRC(1)
BCOR(1)
BDSI(1)
BE(1)
BEKE(1)
BGNE(1)
BLA(1)
BLNK(1)
BOO(1)
BRP(1)
BTBT(1)
BTCM(1)
BUR(1)
BWXT(1)
BYSI(1)
CBAT(1)
CCME(1)
CCRC(1)
CDXC(1)
CELH(1)
CGN(1)
CLOV(1)
CLSK(1)
CMC(1)
CMED(1)
CO(1)
CORT(1)
CORZ(1)
CRIUF(1)
CRMD(1)
CRTO(1)
CSSE(1)
CYDY(1)
DATS(1)
DGW(1)
DKNG(1)
DNMR(1)
DOS(1)
DOYU(1)
DVA(1)
EBIX(1)
EBON(1)
EDU(1)
EHTH(1)
EIGU(1)
ELMS(1)
EMO(1)
ENOB(1)
ENPH(1)
EROS(1)
EVER(1)
EVGO(1)
FANH(1)
FCEL(1)
FD(1)
FFIE(1)
FIZZ(1)
FMCN(1)
FRGT(1)
FRSX(1)
FUV(1)
GAU(1)
GDS(2)
GFRE(1)
GGR(1)
GNPX(1)
GNUS(1)
GNW(1)
GOTU(2)
GOW(1)
GRWG(1)
GWH(2)
HASI(2)
HFFG(1)
HMBL(1)
HPR(1)
HROW(2)
HTHT(1)
HYLN(1)
HYZN(1)
IBAT(1)
IDEX(2)
IIPR(1)
INGN(1)
INPX(1)
INS(1)
IPO(1)
IQE(1)
ITP(1)
JCOM(1)
JD(1)
JKS(1)
KERN(1)
KIDS(1)
KNDI(1)
KRZ(1)
LICY(1)
LK(1)
LKE(1)
LKM(1)
LLEN(1)
LMFD(1)
LMND(1)
LOOP(1)
LTS(1)
LX(1)
MARA(2)
MARK(1)
MDCA(1)
MED(1)
MFC(1)
MNSO(1)
MP(2)
MPLN(1)
MULN(1)
MVMD(1)
MXL(1)
N/A(1)
NAK(1)
NB2(1)
NBEV(1)
NEA(1)
NEWP(1)
NEXCF(1)
NG(1)
NIO(1)
NISN(1)
NKLA(1)
NMC(1)
NNOX(1)
NOBGY(1)
NRGV(1)
NTRA(1)
NYMX(1)
OLAG(1)
ONDS(1)
OPK(1)
OPRA(1)
ORA(1)
OSIS(1)
OTRK(1)
PCLO(1)
PCYO(1)
PETS(1)
PGLC(1)
PGNY(1)
PKK(1)
PLL(2)
PLSE(1)
PLTK(1)
PRED(1)
PRTA(1)
PUMP(1)
PVBC(1)
QPP(1)
RFF(1)
RIDE(1)
RINO(1)
RIOT(1)
ROLTA(1)
RUN(1)
S30(1)
SAX(1)
SDC(1)
SEK(1)
SEV(1)
SGLY(1)
SKYS(1)
SLI(2)
SOL(1)
SOS(1)
SPI(1)
SPRD(1)
SRNE(2)
SSTI(1)
STAA(1)
STEM(1)
STJ(1)
SY(1)
TAL(1)
TELIA(1)
TFC(1)
TGLS(1)
TMC(1)
TMCI(1)
TRE(1)
TRUL(1)
TSP(1)
TTSH(1)
TWTR(1)
UAVS(1)
UNH(1)
UTA(1)
VBIV(1)
VERI(1)
VERU(1)
VIEW(1)
WELL(1)
WINS(1)
WKHS(1)
WORX(1)
WTC(1)
WU(1)
WUBA(1)
XL(1)
XMTR(1)
XXII(1)
YMM(1)
YRIV(1)
YY(1)
ZEN(1)
ZNOG(1)
ZTO(1)
ZYXI(1)
Current Share Price: 1.410
Hindenburg Research
Initial Report Date(2018/05/09)Share Price:16.000
Initial Report Date(2018/05/09)Share Price:16.000
We Believe Genprex Is A Disaster In The Making
Details Link > Genprex was founded by a team that led Introgen, one of the more notable biotech catastrophes that declared bankruptcy amidst allegations of repeatedly misleading investors.
Genprex’s product candidate is based on IP that was abandoned in Introgen’s bankruptcy because it “provide[d] no value to the debtors and [was] of no interest to the potential purchasers”.
The product candidate looks to already be in trouble. The company’s Phase II trial has been suspended since April 2016.
Genprex’s underwriter, Network 1 Financial, has led or participated in the underwritings of recent disasters such as LongFin, Long Blockchain, Adomani, and CIFS among others.
Texas-based Genprex uses a small Boca Raton, Florida-based auditor and has been heavily promoted on penny stock websites and newsletters. We believe Genprex is a zero in the making.
By wantattse
Start